Diverting loop ileostomy and colonic lavage: An alternative to total abdominal colectomy for the treatment of severe, complicated clostridium difficile associated disease

Annals of Surgery

Volumn 254, Issue 3, 2011, Pages 423-429

  Neal, Matthew D ^a   Alverdy, John C ^b   Hall, Daniel E ^a,c   Simmons, Richard L ^a   Zuckerbraun, Brian S ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROLYTE; MACROGOL 3350; VANCOMYCIN; HYPERTENSIVE AGENT; IMMUNOSUPPRESSIVE AGENT; METRONIDAZOLE;

ADULT; AGED; ANTIBIOTIC THERAPY; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COLON LAVAGE; CONFERENCE PAPER; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG INSTILLATION; FEMALE; HUMAN; ILEOSTOMY; INTESTINE INFECTION; LAPAROSCOPIC SURGERY; LARGE INTESTINE DISEASE; LOOP ILEOSTOMY; LUNG EMBOLISM; MALE; MORTALITY; PEROPERATIVE CARE; PNEUMONIA; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; REOPERATION; SURGICAL INFECTION; TOTAL COLON RESECTION; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; ARTIFICIAL VENTILATION; CLOSTRIDIUM DIFFICILE; COLON; DISEASE SEVERITY; IMMUNOSUPPRESSIVE TREATMENT; INTRAOPERATIVE PERIOD; LAPAROSCOPIC LOOP ILEOSTOMY; LEUKOCYTOSIS; MEDICAL HISTORY; MINIMALLY INVASIVE SURGERY; OUTCOME ASSESSMENT; RISK REDUCTION; SEX DIFFERENCE; SURGICAL APPROACH; SURGICAL PATIENT; SURGICAL RISK; SURGICAL TECHNIQUE; THROMBOCYTOPENIA; TOTAL ABDOMINAL COLECTOMY;

AGED; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLECTOMY; COLON; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; ILEOSTOMY; MALE; MIDDLE AGED; ODDS RATIO; PENNSYLVANIA; POLYETHYLENE GLYCOLS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; THERAPEUTIC IRRIGATION; VANCOMYCIN;

EID: 80052277400     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31822ade48     Document Type: Conference Paper

References (28)

1. Fekety R, Shah AB. Diagnosis and treatment of Clostridium difficile colitis. JAMA. 1993;269(1):71-75. (Pubitemid 23006526)
2. Jr Seder CW, VillalbaMR, Robbins J, et al. Early colectomymay be associated with improved survival in fulminant Clostridium difficile colitis: an 8-year experience. Am J Surg. 2009;197(3):302-307.
3. Koss K, Clark MA, Sanders DS, et al. The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Dis. 2006;8(2):149-154. (Pubitemid 43372465)
4. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005;366(9491):1079-1084. (Pubitemid 41338761)
5. Eggertson L. C. difficile strain 20 times more virulent. CMAJ. 2005;172(10):1279.
6. Loo VG, Poirier L,MillerMA, et al. A predominantly clonalmulti- institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):2442-9. (Pubitemid 41770165)
7. Gash K, Brown E, Pullyblank A. Emergency subtotal colectomy for fulminant Clostridium difficile colitis-is a surgical solution considered for all patients? Ann R Coll Surg Engl. 2010;92(1):56-60.
8. Dallal RM, Harbrecht BG, BoujoukasAJ, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg. 2002;235(3):363-372. (Pubitemid 34183887)
9. Longo WE,Mazuski JE,VirgoKS, et al.Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum. 2004;47(10):1620-1626. (Pubitemid 39331972)
10. Sailhamer EA, CarsonK, ChangY, et al. Fulminant Clostridium difficile colitis: Patterns of care and predictors of mortality. Arch Surg. 2009;144(5):433-439; discussion 439-440.
11. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431-455.
12. Hall JF, Berger D. Outcome of colectomy for Clostridium difficile colitis: a plea for early surgical management. Am J Surg. 2008;196(3):384-388.
13. Dudukgian H, Sie E, Gonzalez-Ruiz C, et al. C. difficile colitis-predictors of fatal outcome. J Gastrointest Surg. 2010;14(2):315-322.
14. Byrn JC, Maun DC, Gingold DS, et al. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg. 2008;143(2):150-154; discussion 155. (Pubitemid 351281618)
15. Synnott K, Mealy K, Merry C, et al. Timing of surgery for fulminating pseudomembranous colitis. Br J Surg. 1998;85(2):229-231. (Pubitemid 28099945)
16. Jaber MR, Ruan JH, Fung WL, et al. Are vasopressor use and mechanical ventilation the only predictors of worse outcome for fulminant Clostridium difficile infection? Am J Surg. 2009;198(4):581-582.
17. Lipsett PA, Samantaray DK, Tam ML, et al. Pseudomembranous colitis: a surgical disease? Surgery. 1994;116(3):491-496. (Pubitemid 24286774)
18. Trudel JL, Descĥenes M, Mayrand S, et al. Toxic megacolon complicating pseudomembranous enterocolitis. DisColon Rectum. 1995;38(10):1033-1038.
19. Medich DS, Lee KK, Simmons RL, et al. Laparotomy for fulminant pseudomembranous colitis. Arch Surg. 1992;127(7):847-852; discussion 852-853.
20. Dharmarajan T, Sipalay M, Shyamsundar R, et al. Co-morbidity, not age predicts adverse outcome in Clostridium difficile colitis. World J Gastroenterol. 2000;6(2):198-201. (Pubitemid 30223594)
21. Hardt C, Berns T, Treder W, et al. Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein. World J Gastroenterol. 2008;14(27):4338-4341.
22. Siro CA, Bastos PG, Knaus WA, et al. APACHE II scores in the prediction of multiple organ failure syndrome. Arch Surg. 1991;126(4):528-529.
23. Grundfest-Broniatowski S, Quader M, Alexander F, et al. Clostridium difficile colitis in the critically ill. Dis Colon Rectum. 1996;39(6):619-623. (Pubitemid 26181126)
24. Louie TJ, Miller MA, Mullane KM, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364(5):422-431.
25. Lowy I, Molrine DC, Leav BA, et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med. 2010;362(3):197-205.
26. McEllistrem MC, Carman RJ, Gerding DN, et al. A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes. Clin Infect Dis. 2005;40(2):265-272. (Pubitemid 40110672)
27. Rubin MS, Bodenstein LE, Kent KC. Severe Clostridium difficile colitis. Dis Colon Rectum. 1995;38(4):350-354.
28. Belmares J, Gerding DN, Parada JP, et al. Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system. J Infect. 2007;55(6):495-501. (Pubitemid 350082477)